News Breaks |
|
|
| January 22, 2013 |
| 05:42 EDT |  | SCR | Simcere sells 35% equity interest in Shanghai Celgen for RMB 302M
Simcere Pharmaceutical Group announced that the company entered into a share transfer agreement with Devont Asset Management Limited on January 15 to sell an approximately 35% equity interest in Shanghai Celgen Bio-Pharmaceutical for a cash consideration of RMB 302M. Simcere indirectly acquired an approximately 35% equity interest in Shanghai Celgen in August 2009. Upon completion of this transaction, Simcere will no longer hold any equity interest in Shanghai Celgen. |
|
|
News For SCR From The Last 14 Days Check below for free stories on SCR the last two weeks. |
|
|
| There are no results for SCR |
|
|
|
|
